Effectiveness of Instrumental Rehabilitation in Patients With Adhesive Capsulitis
Launched by MOHAMMED V SOUISSI UNIVERSITY · Jan 4, 2025
Trial Information
Current as of August 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment for patients with adhesive capsulitis, commonly known as frozen shoulder. The treatment combines passive mobilization and functional rehabilitation using a robotic exoskeleton, which is a type of robotic device that helps patients move their arms more easily. Researchers want to see if this robotic training is more effective than traditional rehabilitation methods in improving shoulder pain and movement.
To participate in this trial, individuals must be over 18 years old and have shoulder pain or limited movement due to adhesive capsulitis, which can occur on its own or alongside other health conditions like diabetes. However, people with certain issues, such as cognitive impairment, a history of shoulder surgery, or recent shoulder injuries, cannot participate. Those who join the study can expect to engage in sessions using this advanced robotic device as part of their rehabilitation, helping them regain shoulder function. The trial is currently recruiting participants, so it’s a great opportunity for eligible patients looking for new treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients \>18 years of age
- • Shoulder pain and/or movement limitation
- • Idiopathic AC or associated with confirmed systemic disease (e.g., diabetes or dyslipidemia)
- Exclusion Criteria:
- • Cognitive impairment
- • History of surgery
- • Fracture or dislocation of the shoulder
- • History of shoulder tendinopathy
- • History of inflammatory or degenerative disease
- • Infection
- • Neurological disease (Parkinson's disease, stroke, multiple sclerosis, neurological
- • Manipulation under anesthesia, hydro dilation, platelet rich plasma or hyaluronic acid infiltration within the last 6 months
About Mohammed V Souissi University
Mohammed V Souissi University is a prominent academic institution in Morocco, dedicated to advancing research and education across various disciplines, including health sciences. The university actively engages in clinical trials to explore innovative therapeutic interventions and contribute to the body of medical knowledge. With a commitment to ethical standards and collaboration, Mohammed V Souissi University aims to enhance patient care and foster scientific advancements through rigorous research methodologies and multidisciplinary partnerships. Its initiatives reflect a strong dedication to improving health outcomes and addressing clinical challenges within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rabat, , Morocco
Patients applied
Trial Officials
samia karkouri, professor
Study Chair
Mohammed V Souissi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported